Cargando…
Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria
IgG and IgG3 antibodies to merozoite surface protein-2 (MSP-2) of Plasmodium falciparum have been associated with protection from clinical malaria in independent studies. We determined whether this protection was allele-specific by testing whether children who developed clinical malaria lacked IgG/I...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847195/ https://www.ncbi.nlm.nih.gov/pubmed/20398182 http://dx.doi.org/10.1111/j.1365-3024.2009.01178.x |
_version_ | 1782179545592365056 |
---|---|
author | OSIER, F H A MURUNGI, L M FEGAN, G TUJU, J TETTEH, K K BULL, P C CONWAY, D J MARSH, K |
author_facet | OSIER, F H A MURUNGI, L M FEGAN, G TUJU, J TETTEH, K K BULL, P C CONWAY, D J MARSH, K |
author_sort | OSIER, F H A |
collection | PubMed |
description | IgG and IgG3 antibodies to merozoite surface protein-2 (MSP-2) of Plasmodium falciparum have been associated with protection from clinical malaria in independent studies. We determined whether this protection was allele-specific by testing whether children who developed clinical malaria lacked IgG/IgG3 antibodies specific to the dominant msp2 parasite genotypes detected during clinical episodes. We analysed pre-existing IgG and IgG1/IgG3 antibodies to antigens representing the major dimorphic types of MSP-2 by ELISA. We used quantitative real-time PCR to determine the dominant msp2 alleles in parasites detected in clinical episodes. Over half (55%, 80/146) of infections contained both allelic types. Single or dominant IC1- and FC27-like alleles were detected in 46% and 42% of infections respectively, and both types were equally dominant in 12%. High levels of IgG/IgG3 antibodies to the FC27-like antigen were not significantly associated with a lower likelihood of clinical episodes caused by parasites bearing FC27-like compared to IC1-like alleles, and vice versa for IgG/IgG3 antibodies to the IC1-like antigen. These findings were supported by competition ELISAs which demonstrated the presence of IgG antibodies to allele-specific epitopes within both antigens. Thus, even for this well-studied antigen, the importance of an allele-specific component of naturally acquired protective immunity to malaria remains to be confirmed. |
format | Text |
id | pubmed-2847195 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-28471952010-04-08 Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria OSIER, F H A MURUNGI, L M FEGAN, G TUJU, J TETTEH, K K BULL, P C CONWAY, D J MARSH, K Parasite Immunol Original Articles IgG and IgG3 antibodies to merozoite surface protein-2 (MSP-2) of Plasmodium falciparum have been associated with protection from clinical malaria in independent studies. We determined whether this protection was allele-specific by testing whether children who developed clinical malaria lacked IgG/IgG3 antibodies specific to the dominant msp2 parasite genotypes detected during clinical episodes. We analysed pre-existing IgG and IgG1/IgG3 antibodies to antigens representing the major dimorphic types of MSP-2 by ELISA. We used quantitative real-time PCR to determine the dominant msp2 alleles in parasites detected in clinical episodes. Over half (55%, 80/146) of infections contained both allelic types. Single or dominant IC1- and FC27-like alleles were detected in 46% and 42% of infections respectively, and both types were equally dominant in 12%. High levels of IgG/IgG3 antibodies to the FC27-like antigen were not significantly associated with a lower likelihood of clinical episodes caused by parasites bearing FC27-like compared to IC1-like alleles, and vice versa for IgG/IgG3 antibodies to the IC1-like antigen. These findings were supported by competition ELISAs which demonstrated the presence of IgG antibodies to allele-specific epitopes within both antigens. Thus, even for this well-studied antigen, the importance of an allele-specific component of naturally acquired protective immunity to malaria remains to be confirmed. Blackwell Publishing Ltd 2010-03 /pmc/articles/PMC2847195/ /pubmed/20398182 http://dx.doi.org/10.1111/j.1365-3024.2009.01178.x Text en © 2010 Blackwell Publishing Ltd http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. |
spellingShingle | Original Articles OSIER, F H A MURUNGI, L M FEGAN, G TUJU, J TETTEH, K K BULL, P C CONWAY, D J MARSH, K Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria |
title | Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria |
title_full | Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria |
title_fullStr | Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria |
title_full_unstemmed | Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria |
title_short | Allele-specific antibodies to Plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria |
title_sort | allele-specific antibodies to plasmodium falciparum merozoite surface protein-2 and protection against clinical malaria |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2847195/ https://www.ncbi.nlm.nih.gov/pubmed/20398182 http://dx.doi.org/10.1111/j.1365-3024.2009.01178.x |
work_keys_str_mv | AT osierfha allelespecificantibodiestoplasmodiumfalciparummerozoitesurfaceprotein2andprotectionagainstclinicalmalaria AT murungilm allelespecificantibodiestoplasmodiumfalciparummerozoitesurfaceprotein2andprotectionagainstclinicalmalaria AT fegang allelespecificantibodiestoplasmodiumfalciparummerozoitesurfaceprotein2andprotectionagainstclinicalmalaria AT tujuj allelespecificantibodiestoplasmodiumfalciparummerozoitesurfaceprotein2andprotectionagainstclinicalmalaria AT tettehkk allelespecificantibodiestoplasmodiumfalciparummerozoitesurfaceprotein2andprotectionagainstclinicalmalaria AT bullpc allelespecificantibodiestoplasmodiumfalciparummerozoitesurfaceprotein2andprotectionagainstclinicalmalaria AT conwaydj allelespecificantibodiestoplasmodiumfalciparummerozoitesurfaceprotein2andprotectionagainstclinicalmalaria AT marshk allelespecificantibodiestoplasmodiumfalciparummerozoitesurfaceprotein2andprotectionagainstclinicalmalaria |